S.et al (2017)
Although it is rare, death in adults resulting from gastrointestinal complications has occurred in the past
Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
Relatively common side effects Internal bleeding or itching at the injection site, diarrhea, constipation, headache Severe side effects hypoglycemia, pancreatitis, bowel obstruction, palpitations *Although GLP-1 alone rarely causes hypoglycemia, it has been reported that combined use with insulin or oral hypoglycemic agents can cause severe hypoglycemia
GLP-1 medications are designed to bind to cells in your body that have GLP-1 receptors, just like your natural GLP-1 hormone would
Our side effect comparison guide can help you prepare for that conversation